OGI

OrganiGram Holdings Inc.

Price

$1.26

return (12m)

-21.25%

p/e

2.73

p/bv

0.49

DIVIDEND YIELD

0.00%

OGI price

OrganiGram Holdings

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment OGI

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

32.65%

3 months

13.51%

1 year

-21.25%

2 years

-37.62%

5 years

-87.65%

10 years

-71.36%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals OGI

Valuation

P/E

2.73

Sector -4.32

Industry -4.32

P/BV

0.49

Sector 2.14

Industry 2.14

P/Revenue (PSR)

0.75

Sector 2.10

Industry 2.10

EV/EBITDA

15.65

Sector -205.63

Industry -205.63

EV/EBIT

45.35

Sector -44.80

Industry -44.80

P/EBITDA

12.81

Sector -20.37

Industry -20.37

P/EBIT

-33.89

Sector -30.67

Industry -30.67

P/Total Assets

0.29

Sector 1.28

Industry 1.28

P/Net Current Assets

-4.31

Sector -11.26

Industry -11.26

P/Working Capital

1.36

Sector -1.28

Industry -1.28

EPS

0.46

Sector -2.01

Industry -2.01

BVPS

2.56

Sector 1.94

Industry 1.94

Efficiency

Gross Margin

36.52%

Sector 37.97%

Industry 37.97%

EBITDA Margin

14.61%

Sector -16,590.01%

Industry -16,590.01%

EBIT Margin

5.04%

Sector -4,202,867.70%

Industry -4,202,867.70%

Operating Margin

-2.23%

Sector -37.03%

Industry -37.03%

Net Profit Margins

27.62%

Sector -38.20%

Industry -38.20%

Asset Turnover

0.13

Sector 0.03

Industry 0.03

Profitability

ROE

17.80%

Sector -62.10%

Industry -62.10%

ROA

10.53%

Sector -64.73%

Industry -64.73%

ROIC

3.67%

Sector -1,826.60%

Industry -1,826.60%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

2.61

Sector 2.92

Industry 2.92

Net Debt / EBITDA

0.39

Sector -13,814,519.62

Industry -13,814,519.62

Net Debt / EBIT

1.12

Sector -3.00

Industry -3.00

Net Debt / Equity

0.01

Sector -1.09

Industry -1.09

Gross Debt / Equity

0.04

Sector 0.00

Industry 0.00

Equity/Assets

0.59

Sector 0.43

Industry 0.43

Liabilities/Assets

0.41

Sector 0.40

Industry 0.40

Growth

5Y Revenue CAGR

25.29%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF OrganiGram Holdings ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$1.26

Fair Value

$5.15

Upside Return potential.

308.53%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals OGI

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
OGI OrganiGram Holdings Inc.	$1.26	-21.25%	0.00%	2.73	0.49	17.80%	27.62%
JNJ Johnson & Johnson	$273.04	56.89%	1.92%	31.24	7.73	24.76%	21.48%
PFE Pfizer Inc.	$27.97	17.68%	6.15%	36.48	1.86	5.11%	6.86%
ABBV AbbVie Inc.	$264.52	29.61%	2.57%	74.50	-79.29	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.92	-11.58%	4.00%	11.35	6.03	53.11%	35.32%
MRK Merck & Co. Inc.	$150.66	79.29%	2.21%	118.22	8.93	7.56%	4.77%
AZN AstraZeneca PLC	$166.71	7.18%	1.92%	24.75	5.13	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.28	47.06%	3.73%	14.81	6.16	41.59%	18.87%
ZTS Zoetis Inc.	$77.17	-49.61%	2.64%	12.45	10.35	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$828.50	45.54%	0.43%	20.07	2.74	13.65%	27.86%
AMGN Amgen Inc.	$443.84	56.58%	2.25%	26.93	20.15	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$108.64	51.27%	0.00%	30.63	88.25	288.14%	24.86%
MCK McKesson Corporation	$873.79	27.39%	0.38%	22.35	-78.88	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$547.59	38.59%	0.00%	31.74	6.90	21.76%	35.00%
CAH Cardinal Health Inc.	$232.37	58.90%	0.89%	34.62	-20.14	-58.20%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$38.50	1.69%	0.00%	12.30	2.23	18.14%	18.89%
BIIB Biogen Inc.	$218.12	56.57%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

OGI Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT OrganiGram Holdings

OrganiGram Holdings Inc.

Average Investor10 user rating

4.0 (0 people)

United States

16 years

Founded: 2010

2011

Time since IPO - 15 years

517

Employees

OrganiGram Holdings Inc. (United States) is listed on the Nasdaq and has a market capitalization of $168.08 million, with shareholders equity totaling $345.92 million.

The company employs approximately 517 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, OrganiGram Holdings Inc. reported $222.89 million in revenue, generating net income of $61.57 million.

Key financial metrics include a P/E ratio of 2.73, a price-to-book (P/B) ratio of 0.49, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker OGI.

Market cap

$168.08 million

Net worth

$345.92 million

$345,920,000.00

Assets

$584.48 million

$584,480,000.00

Total Shares Outstanding

135.00 million

135,000,000

Average Daily Trading Volume

$989.47 Thousand

$989,465.66

Sector

Health Care

Industry

Biotechnology

OGI

OGI revenue and profits

Financial Results OGI

DRAG THE FRAME TO SEE MORE DATA

OGI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

JNJ - Johnson & Johnson

$273.04 56,88% (12M)

P/E

31.24

1.92%

ROE

24.76%

P/BV

7.73

ABBV - AbbVie

$264.52 31,52% (12M)

P/E

74.50

2.57%

ROE

-106.44%

P/BV

-79.29

AZN - AstraZeneca

$166.71 5,96% (12M)

P/E

24.75

1.92%

ROE

20.74%

P/BV

5.13

PFE - Pfizer

$27.97 19,06% (12M)

P/E

36.48

6.15%

ROE

5.11%

P/BV

1.86

NVO - Novo Nordisk

$46.92 --10,99% (12M)

P/E

11.35

4.00%

ROE

53.11%

P/BV

6.03

TEVA - Teva Pharmaceutical

$36.93 103,81% (12M)

P/E

61.95

0.00%

ROE

9.10%

P/BV

5.64

ARGX - argenx

$1,011.11 49,28% (12M)

P/E

3.76

0.00%

ROE

109.85%

P/BV

4.13

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

JNJ - Johnson & Johnson

$273.04 56,88% (12 M)

P/L

31.24

1.92%

ROE

24.76%

P/VP

7.73

ABBV - AbbVie

$264.52 31,52% (12 M)

P/L

74.50

2.57%

ROE

-106.44%

P/VP

-79.29

AZN - AstraZeneca

$166.71 5,96% (12 M)

P/L

24.75

1.92%

ROE

20.74%

P/VP

5.13

PFE - Pfizer

$27.97 19,06% (12 M)

P/L

36.48

6.15%

ROE

5.11%

P/VP

1.86

NVO - Novo Nordisk

$46.92 --10,99% (12 M)

P/L

11.35

4.00%

ROE

53.11%

P/VP

6.03

TEVA - Teva Pharmaceutical

$36.93 103,81% (12 M)

P/L

61.95

0.00%

ROE

9.10%

P/VP

5.64

ARGX - argenx

$1,011.11 49,28% (12 M)

P/L

3.76

0.00%

ROE

109.85%

P/VP

4.13

Frequently Asked Questions

What is the price of OrganiGram Holdings (OGI) today?

A cotação de OrganiGram Holdings (OGI) hoje está em US$ 1.26, com uma variação de -21.25% em relação ao último ano. A cotação de OrganiGram Holdings (OGI) iniciou o ano negociando na casa dos US$ 1.68 e hoje está em US$ 1.26. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de OrganiGram Holdings (OGI) e dados de ações do Ibovespa e mercados internacionais.

Quando OrganiGram Holdings (OGI) paga dividendos?

OrganiGram Holdings (OGI) não distribuiu dividendos no último ano.

Is OrganiGram Holdings (OGI) a good investment?

Atualmente, OrganiGram Holdings (OGI) está cotada a US$ 1.26, com um P/L de 2.73, representando um desvio de -73% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -21.25 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -21.25%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy OrganiGram Holdings (OGI) stock?

Investir em ações de OrganiGram Holdings (OGI) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of OrganiGram Holdings (OGI) yield today?

A rentabilidade de OrganiGram Holdings (OGI) foi de 32.65% no último mês, -21.25% no último ano e -87.65% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de OrganiGram Holdings (OGI) hoje, o investimento total seria de US$ 126.00, com base na cotação atual de US$ 1.26.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 99.23
Em 5 anos: US$ 15.56
Em 10 anos: US$ 36.09

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

OGI

OrganiGram Holdings Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment OGI

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING OGI WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT OrganiGram Holdings

OrganiGram Holdings Inc.

United States

16 years

2011

517

PROFIT X PRICE OGI

Financial Results OGI

OGI cash flow

Asset, Revenue and Profit Growth - OGI

OGI balance sheet

BFRA - Biofrontera

JNJ - Johnson & Johnson

ABBV - AbbVie

AZN - AstraZeneca

PFE - Pfizer

NVO - Novo Nordisk

TEVA - Teva Pharmaceutical

ARGX - argenx

BFRA - Biofrontera

JNJ - Johnson & Johnson

ABBV - AbbVie

AZN - AstraZeneca

PFE - Pfizer

NVO - Novo Nordisk

TEVA - Teva Pharmaceutical

ARGX - argenx

Frequently Asked Questions